Vaxxas gets $20M for vaccine that can be worn as a patch

A Cambridge startup called Vaxxas that’s developing vaccines worn on the skin as patches just raised a $20 million Series B. The funding will be used to bring its Nanopatch platform to clinical trial, and to flesh out its pipeline of needle-free vaccines. The Nanopatch works by riling up the immune cells just below the skin’s surface, inducing […]